Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Corporate Action

· NSE 🔴 High Importance Neutral
📢 Key Event
Allotment of 94,000 shares under ESOP 2022
🔄 What Changed
Paid-up capital rose to Rs. 13,18,58,940; shares increased to 6,59,29,470
🔮 What's Next
NA
💡 Investor Takeaway
Share count and capital grew due to ESOP issuance.

Jagsonpal Pharmaceuticals announced the allotment of 94,000 equity shares of Rs. 2 each under its Employee Stock Option Plan 2022, increasing paid-up capital from Rs. 13,16,70,940 to Rs. 13,18,58,940 and total shares from 6,58,35,470 to 6,59,29,470, effective July 15, 2026.

📄 View Original Announcement (PDF)

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day